Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of precision medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age-related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Nov 27, 2023

Dr. Lishan Aklog, CEO of Lucid Diagnostics, discusses the current diagnostic landscape for esophageal cancer and the need for early detection. The current diagnostic tool, an upper endoscopy, is an invasive procedure requiring anesthesia.  The EsoGuard, a noninvasive simple cell collection procedure, uses molecular...


Nov 27, 2023

Dr. Lishan Aklog, CEO of Lucid Diagnostics, discusses the current diagnostic landscape for esophageal cancer and the need for early detection. The current diagnostic tool, an upper endoscopy, is an invasive procedure requiring anesthesia.  The EsoGuard, a noninvasive simple cell collection procedure, uses molecular...


Sep 28, 2023

Eric Mayer, CEO of New Day Diagnostics, is tapping into the trend for more user-friendly diagnostics that patients can use to test themselves for making medical decisions. While blood draw facilities and complex testing will always be a component of healthcare, as technology progresses, more at-home testing will become...


Sep 28, 2023

Eric Mayer, CEO of New Day Diagnostics, is tapping into the trend for more user-friendly diagnostics that patients can use to test themselves for making medical decisions. While blood draw facilities and complex testing will always be a component of healthcare, as technology progresses, more at-home testing will become...


Sep 5, 2023

Mark McDonough, the CEO of ChromaCode, is leveraging high-definition PCR testing to overcome the limitations of conventional PCR to identify biomarkers of infectious diseases and cancer. While gene sequencing can provide valuable information, it requires more tissue, is expensive, and requires at least a week for...